Literature DB >> 20661404

Alzheimer's disease: diverse aspects of mitochondrial malfunctioning.

Renato X Santos1, Sónia C Correia, Xinglong Wang, George Perry, Mark A Smith, Paula I Moreira, Xiongwei Zhu.   

Abstract

Alzheimer's disease is a progressive neurodegenerative disorder, either assuming a sporadic, age-associated, late-onset form, or a familial form, with early onset, in a smaller fraction of the cases. Whereas in the familial cases several mutations have been identified in genes encoding proteins related with the pathogenesis of the disease, for the sporadic form several causes have been proposed and are currently under debate. Mitochondrial dysfunction has surfaced as one of the most discussed hypotheses acting as a trigger for the pathogenesis of Alzheimer's disease. Mitochondria assume central functions in the cell, including ATP production, calcium homeostasis, reactive oxygen species generation, and apoptotic signaling. Although their role as the cause of the disease may be controversial, there is no doubt that mitochondrial dysfunction, abnormal mitochondrial dynamics and degradation by mitophagy occur during the disease process, contributing to its onset and progression.

Entities:  

Keywords:  Alzheimer's disease; mitochondria; mitochondrial dynamics; mitochondrial dysfunction

Mesh:

Year:  2010        PMID: 20661404      PMCID: PMC2907118     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  118 in total

1.  Alzheimer's disease is associated with reduced expression of energy metabolism genes in posterior cingulate neurons.

Authors:  Winnie S Liang; Eric M Reiman; Jon Valla; Travis Dunckley; Thomas G Beach; Andrew Grover; Tracey L Niedzielko; Lonnie E Schneider; Diego Mastroeni; Richard Caselli; Walter Kukull; John C Morris; Christine M Hulette; Donald Schmechel; Joseph Rogers; Dietrich A Stephan
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-10       Impact factor: 11.205

Review 2.  The mitochondrial impairment, oxidative stress and neurodegeneration connection: reality or just an attractive hypothesis?

Authors:  Hirokazu Fukui; Carlos T Moraes
Journal:  Trends Neurosci       Date:  2008-04-09       Impact factor: 13.837

3.  Cyclophilin D deficiency attenuates mitochondrial and neuronal perturbation and ameliorates learning and memory in Alzheimer's disease.

Authors:  Heng Du; Lan Guo; Fang Fang; Doris Chen; Alexander A Sosunov; Guy M McKhann; Yilin Yan; Chunyu Wang; Hong Zhang; Jeffery D Molkentin; Frank J Gunn-Moore; Jean Paul Vonsattel; Ottavio Arancio; John Xi Chen; Shi Du Yan
Journal:  Nat Med       Date:  2008-09-21       Impact factor: 53.440

4.  The amyloid beta-peptide is imported into mitochondria via the TOM import machinery and localized to mitochondrial cristae.

Authors:  Camilla A Hansson Petersen; Nyosha Alikhani; Homira Behbahani; Birgitta Wiehager; Pavel F Pavlov; Irina Alafuzoff; Ville Leinonen; Akira Ito; Bengt Winblad; Elzbieta Glaser; Maria Ankarcrona
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-29       Impact factor: 11.205

5.  Dynamin-like protein 1 reduction underlies mitochondrial morphology and distribution abnormalities in fibroblasts from sporadic Alzheimer's disease patients.

Authors:  Xinglong Wang; Bo Su; Hisashi Fujioka; Xiongwei Zhu
Journal:  Am J Pathol       Date:  2008-07-03       Impact factor: 4.307

Review 6.  Ultrastructure of the mitochondrion and its bearing on function and bioenergetics.

Authors:  Giovanni Benard; Rodrigue Rossignol
Journal:  Antioxid Redox Signal       Date:  2008-08       Impact factor: 8.401

Review 7.  Calcium ions in neuronal degeneration.

Authors:  Urszula Wojda; Elzbieta Salinska; Jacek Kuznicki
Journal:  IUBMB Life       Date:  2008-09       Impact factor: 3.885

Review 8.  Mitochondrial fragmentation in neurodegeneration.

Authors:  Andrew B Knott; Guy Perkins; Robert Schwarzenbacher; Ella Bossy-Wetzel
Journal:  Nat Rev Neurosci       Date:  2008-07       Impact factor: 34.870

Review 9.  Neurofibrillary degeneration in Alzheimer's disease: from molecular mechanisms to identification of drug targets.

Authors:  Jin-Jing Pei; Magnus Sjögren; Bengt Winblad
Journal:  Curr Opin Psychiatry       Date:  2008-11       Impact factor: 4.741

10.  The autophagy-related protein beclin 1 shows reduced expression in early Alzheimer disease and regulates amyloid beta accumulation in mice.

Authors:  Fiona Pickford; Eliezer Masliah; Markus Britschgi; Kurt Lucin; Ramya Narasimhan; Philipp A Jaeger; Scott Small; Brian Spencer; Edward Rockenstein; Beth Levine; Tony Wyss-Coray
Journal:  J Clin Invest       Date:  2008-06       Impact factor: 14.808

View more
  46 in total

1.  Presenilin 2 modulates endoplasmic reticulum (ER)-mitochondria interactions and Ca2+ cross-talk.

Authors:  Enrico Zampese; Cristina Fasolato; Maulilio J Kipanyula; Mario Bortolozzi; Tullio Pozzan; Paola Pizzo
Journal:  Proc Natl Acad Sci U S A       Date:  2011-02-01       Impact factor: 11.205

2.  Editorial: can we improve care for patients with dementia?

Authors:  J E Morley
Journal:  J Nutr Health Aging       Date:  2011-08       Impact factor: 4.075

3.  Mitochondrial Movement and Number Deficits in Embryonic Cortical Neurons from 3xTg-AD Mice.

Authors:  John Z Cavendish; Saumyendra N Sarkar; Mark A Colantonio; Dominic D Quintana; Nadia Ahmed; Brishti A White; Elizabeth B Engler-Chiurazzi; James W Simpkins
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

4.  Familial Alzheimer's disease-associated presenilin-1 alters cerebellar activity and calcium homeostasis.

Authors:  Diego Sepulveda-Falla; Alvaro Barrera-Ocampo; Christian Hagel; Anne Korwitz; Maria Fernanda Vinueza-Veloz; Kuikui Zhou; Martijn Schonewille; Haibo Zhou; Luis Velazquez-Perez; Roberto Rodriguez-Labrada; Andres Villegas; Isidro Ferrer; Francisco Lopera; Thomas Langer; Chris I De Zeeuw; Markus Glatzel
Journal:  J Clin Invest       Date:  2014-02-24       Impact factor: 14.808

Review 5.  Tau-induced neurodegeneration: mechanisms and targets.

Authors:  Cindy Beharry; Leah S Cohen; Jing Di; Kawsar Ibrahim; Susan Briffa-Mirabella; Alejandra del C Alonso
Journal:  Neurosci Bull       Date:  2014-04-15       Impact factor: 5.203

Review 6.  Therapeutics of Neurotransmitters in Alzheimer's Disease.

Authors:  Ramesh Kandimalla; P Hemachandra Reddy
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

Review 7.  Antioxidants in Down syndrome.

Authors:  Ira T Lott
Journal:  Biochim Biophys Acta       Date:  2011-12-21

Review 8.  Progress in Alzheimer's disease.

Authors:  Daniela Galimberti; Elio Scarpini
Journal:  J Neurol       Date:  2011-06-25       Impact factor: 4.849

Review 9.  Multi-Target Drug Candidates for Multifactorial Alzheimer's Disease: AChE and NMDAR as Molecular Targets.

Authors:  Md Sahab Uddin; Abdullah Al Mamun; Md Tanvir Kabir; Ghulam Md Ashraf; May N Bin-Jumah; Mohamed M Abdel-Daim
Journal:  Mol Neurobiol       Date:  2020-09-15       Impact factor: 5.590

10.  Amyloid β peptides modify the expression of antioxidant repair enzymes and a potassium channel in the septohippocampal system.

Authors:  Jorge Durán-González; Edna D Michi; Brisa Elorza; Miriam G Perez-Córdova; Luis F Pacheco-Otalora; Ahmed Touhami; Pamela Paulson; George Perry; Ian V Murray; Luis V Colom
Journal:  Neurobiol Aging       Date:  2013-03-07       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.